Literature DB >> 17386062

Matched pair analysis of ureteroscopy vs. shock wave lithotripsy for the treatment of upper ureteric calculi.

G D Stewart1, S V Bariol, S A Moussa, G Smith, D A Tolley.   

Abstract

There is controversy over whether shock wave lithotripsy (SWL) or ureteroscopy (URS) is the best management of ureteric calculi, especially for stones located in the upper ureter. This study compares URS and SWL management of upper ureteric stones directly for the first time using a different analysis tool, the matched pair analysis study design. This method enables meaningful comparisons to be made on a small number of matched patients, using precise like-for-like matching. Adult patients undergoing primary treatment of solitary radiopaque proximal ureteric stones were identified. Patients with stents, nephrostomies or stones at the pelvi-ureteric junction were excluded. Patients had a minimum of 3 months follow-up. Patients treated by primary URS were matched using four parameters (sex, laterality, stone size and location) to patients treated on a Dornier Compact Delta Lithotriptor. A total of 1479 patients had URS or SWL from which 27 upper ureteric stone matched pairs were identified. Three-month stone free rates were 82% for URS and 89% for SWL (McNemar's test, p=0.625). Re-treatment was required in 11% and 26% following URS and SWL respectively (p=0.219). Forty-one per cent of URS patients required an ancillary treatment, such as stent removal, compared with only 22% of SWL patients (p=0.227). Introduction of a holmium:YAG laser for use with URS improved the stone free rate for URS to 100%. Using a robust like-for-like comparison of similar patients with very similar upper ureteric stones the outcomes following SWL and URS were comparable. Choice of treatment should therefore be based on parameters such as availability of equipment, waiting times and patient preference.

Entities:  

Mesh:

Year:  2007        PMID: 17386062     DOI: 10.1111/j.1742-1241.2007.01296.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  7 in total

Review 1.  Arguments for choosing extracorporeal shockwave lithotripsy for removal of urinary tract stones.

Authors:  Hans-Göran Tiselius; Christian G Chaussy
Journal:  Urolithiasis       Date:  2015-08-28       Impact factor: 3.436

2.  Comparison of ureteroscopic pneumatic lithotripsy and extracorporeal shock wave lithotripsy for the management of proximal ureteral stones: A single center experience.

Authors:  Nadeem Iqbal; Yashfeen Malik; Utbah Nadeem; Maham Khalid; Amna Pirzada; Mehr Majeed; Hajra Arshad Malik; Saeed Akhter
Journal:  Turk J Urol       Date:  2018-05-01

3.  Extracorporeal shock wave lithotripsy in the pediatric population.

Authors:  Caleb P Nelson
Journal:  Urol Res       Date:  2010-07-13

4.  Is shock wave lithotripsy efficient for the elderly stone formers? Results of a matched-pair analysis.

Authors:  Prodromos Philippou; Djelali Lamrani; Konstantinos Moraitis; Christian Bach; Junaid Masood; Noor Buchholz
Journal:  Urol Res       Date:  2011-09-08

5.  Comparative analysis of upper ureteral stones (> 15 mm) treated with retroperitoneoscopic ureterolithotomy and ureteroscopic pneumatic lithotripsy.

Authors:  YunYan Wang; JianQuan Hou; DuanGai Wen; Jun OuYang; JunSong Meng; HaiJun Zhuang
Journal:  Int Urol Nephrol       Date:  2010-02-19       Impact factor: 2.370

6.  Shock wave lithotripsy versus ureteroscopy for ureteral calculi: a prospective assessment of patient-reported outcomes.

Authors:  Jinsung Park; Dong Wook Shin; Jae Hoon Chung; Seung Wook Lee
Journal:  World J Urol       Date:  2012-10-18       Impact factor: 4.226

7.  The effect of stone size on the results of extracorporeal shockwave lithotripsy versus semi-rigid ureteroscopic lithotripsy in the management of upper ureteric stones.

Authors:  Ahmed S El-Abd; Ahmed M Tawfeek; Shawky A El-Abd; Tarik A Gameel; Hasan H El-Tatawy; Magdy A El-Sabaa; Mohamed G Soliman
Journal:  Arab J Urol       Date:  2021-11-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.